Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer
Abstract Background Recent studies have shown that selenium-binding protein 1 (SELENBP1) is significantly down-regulated in a variety of solid tumors. Nevertheless, the clinical relevance of SELENBP1 in human bladder cancer has not been described in any detail, and the molecular mechanism underlying...
Main Authors: | Yulei Wang, Wenzhen Zhu, Xiaoqing Chen, Guangnan Wei, Guosong Jiang, Guochun Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-020-02211-4 |
Similar Items
-
Cell-Type Specific Analysis of Selenium-Related Genes in Brain
by: Alexandru R. Sasuclark, et al.
Published: (2019-05-01) -
Selenium-Binding Protein 1 in Human Health and Disease
by: Mostafa Elhodaky, et al.
Published: (2018-11-01) -
Chimiothérapie ciblant les cellules cancéreuses p53 déficientes
by: Jemaâ, Mohamed
Published: (2012) -
Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
by: Camila B. Piantino, et al.
Published: (2013-01-01) -
Selenium and selenoprotein P1 levels are related to primary open-angle glaucoma
by: Najafi Mohammad, et al.
Published: (2014-01-01)